Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection

• Fehmi Hindilerden,
• İpek Yönal Hindilerden,
• Reyhan Diz Küçükkaya

Affiliations

Fehmi Hindilerden

Department of Hematology, University of Health Sciences, İstanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Turkey

İpek Yönal Hindilerden

Division of Hematology, Department of Internal Medicine, İstanbul University İstanbul School of Medicine, İstanbul, Turkey

Reyhan Diz Küçükkaya

Department of Molecular Biology and Genetics, İstanbul University İstanbul School of Science, İstanbul, Turkey